Literature DB >> 24532565

Overexpression of angiomotin in sinonasal inverted papilloma.

Jang Yul Byun1, Sang Hag Lee, Jae Min Shin, Byoung Joon Baek, Jae Yong Lee.   

Abstract

BACKGROUND: Although inverted papilloma (IP) is one of the most common sinonasal tumors, its etiology and factors associated with tumor progression have not been fully determined. Generally, tumorigenesis or tumor growth requires angiogenesis to feed tumor cells. Angiomotin is a recently discovered protein that regulates migration and tubule formation in endothelial cells. It has been reported that angiomotin affects angiostatin (circulating inhibitor of angiogenesis), resulting in promotion of angiogenesis. Thus, we evaluated the expression and distribution of angiomotin in sinonasal IP, compared to normal control tissue.
METHODS: The study included 10 subjects with sinonasal IP and 5 normal controls. Ethmoid sinus mucosa obtained during reduction of blowout fractures was used as a normal control. Reverse transcriptase-polymerase chain reaction (RT-PCR), real-time PCR, immunohistochemistry, and Western blot analysis were used to assess the expression, intensity, and distribution of angiomotin in tissues.
RESULTS: Positive bands for angiomotin were seen in all specimens by RT-PCR. The expression level of angiomotin was significantly upregulated in IP tissues versus normal sinus mucosa by real-time PCR. Immunohistochemistry revealed positive reactions on endothelial cells of capillaries and small vessels within the tumor and normal tissues, but the positivity was significantly stronger in IP. Western blot analysis showed that expression levels of angiomotin were increased in IP compared to normal sinus mucosa.
CONCLUSION: Angiomotin, a novel protein in angiogenesis, was overexpressed in IP. Although it is not an etiological or initiating factor in tumor development, it seems to be associated with progression and growth of IP via promoting angiogenesis.
© 2014 ARS-AAOA, LLC.

Entities:  

Keywords:  angiogenesis; angiomotin; angiostatin; ethmoid sinus mucosa; inverted papilloma; sinonasal

Mesh:

Substances:

Year:  2014        PMID: 24532565     DOI: 10.1002/alr.21293

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  6 in total

1.  Advances in recurrence and malignant transformation of sinonasal inverted papillomas.

Authors:  Qingjia Sun; Lifeng An; Jun Zheng; Dongdong Zhu
Journal:  Oncol Lett       Date:  2017-04-24       Impact factor: 2.967

Review 2.  Etiology of sinonasal inverted papilloma: An update.

Authors:  Pranit R Sunkara; Anirudh Saraswathula; Murugappan Ramanathan
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-08-24

3.  Low prevalence of human papillomavirus infection in sinonasal inverted papilloma and oncocytic papilloma.

Authors:  Huan Wang; Changwen Zhai; Juan Liu; Jingjing Wang; Xicai Sun; Li Hu; Dehui Wang
Journal:  Virchows Arch       Date:  2019-12-03       Impact factor: 4.064

Review 4.  The physiological role of Motin family and its dysregulation in tumorigenesis.

Authors:  Tingting Huang; Yuhang Zhou; Jinglin Zhang; Alfred S L Cheng; Jun Yu; Ka Fai To; Wei Kang
Journal:  J Transl Med       Date:  2018-04-12       Impact factor: 5.531

Review 5.  Etiology of sinonasal inverted papilloma: A narrative review.

Authors:  Ming-Jie Wang; Julia E Noel
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2016-12-21

6.  MiR-126 in intestinal-type sinonasal adenocarcinomas: exosomal transfer of MiR-126 promotes anti-tumour responses.

Authors:  Marco Tomasetti; Massimo Re; Federica Monaco; Simona Gaetani; Corrado Rubini; Andrea Bertini; Ernesto Pasquini; Cristiana Bersaglieri; Massimo Bracci; Sara Staffolani; Mariastella Colomba; Armando Gregorini; Matteo Valentino; Adriano Tagliabracci; Massimo Bovenzi; Jiri Neuzil; Monica Amati; Lory Santarelli
Journal:  BMC Cancer       Date:  2018-09-17       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.